
|Articles|June 20, 2019
Thrive or Die in the Omnichannel Era
Author(s)BioPharm Communications
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5